- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05892003
Scot Sweet Study (Interaction of a Non-nutritive Sweetener With a High-fibre Weight Loss Diet) (SSS)
Healthy Diets for a Healthy Weight: Exploring Physiological Mechanisms Related to Dietary Fibre and Non-Nutritive Sweeteners
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aberdeen, United Kingdom, AB25 2ZD
- Rowett Institute, University of Aberdeen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- healthy but overweight/obese (BMI 28-40kg/m2) males and females (postmenopausal, using the oral contraceptive pill or some form of hormonal contraceptive)
- moderate habitual fibre intake (18-23g/day)
Exclusion Criteria:
Medication exclusion criteria:
- antibiotic use (within the past 3 months due to impact on gut microbiota)
- anti-depressants (current)
- smoking or vaping
- weight loss medication
Medical exclusion criteria:
- Females who are planning to be pregnant, are pregnant or are breastfeeding
- Anyone with food allergies, self-reported food sensitivity or intolerance
- Anyone with coeliac disease or gluten intolerance
- Anyone taking medication which may affect their appetite
- Anyone with an eating disorder
- Anyone with diabetes
- Anyone with a gastrointestinal disorder, kidney disease, liver disease or gout
- Anyone suffering from a psychiatric disorder or any type of substance abuse
- Anyone suffering from unregulated thyroid disease
Other exclusion criteria:
- Anyone following a vegetarian or vegan diet
- Anyone following a current weight loss programme (that may be affecting lifestyle, physical activity & diet) or undergone gastric band/reduction surgery
- Anyone with unsuitable veins for blood sampling
- Anyone who is unable to fluently speak, read and understand English
- Anyone who is unable to comply to an alcohol-free diet for 6 weeks
Current sweetener consumption will not be an exclusion criteria as the Phase 1 - CTRL and Phase 2 - HF WL diets will provide enough of a washout (4 weeks) before the Phase 3 diets containing sucralose are consumed. Participants who do habitually consume sweeteners will be asked not to use them during the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Control-High Fibre Weight Loss-High Fibre Non-Nutritive Sweetener Weight Loss: CTRL-HF WL-HF-NNS WL
|
Control diet (30% Fat, 15% Protein, 55% Carbohydrate, Fibre rising from 10 to 16g/d).
Fed to energy balance (1.5 x Resting Metabolic Rate, RMR).
Other Names:
High Fibre Weight Loss diet (30% Fat, 15% Protein, 55% Carbohydrate).
Fed to energy deficit (100% RMR).
The quantity of fructo-oligosaccharides (FOS) will be fixed at 20g/day for all kcal levels with additional fibre coming from the diet provided.
The FOS will be split over breakfast, lunch and dinner in drinks/yoghurts which will be compulsory to consume.
Other Names:
High Fibre and Non-Nutritive Sweetener Weight Loss diet (30% Fat, 15% Protein, 55% Carbohydrate).
Fed to energy deficit (100% RMR).
The quantity of fructo-oligosaccharides (FOS) and non-nutritive sweetener (sucralose) will be fixed at 20g/day and 30mg/day respectively for all kcal levels with additional fibre coming from the diet provided.
The FOS and sucralose will be split over breakfast, lunch and dinner in drinks/yoghurts which will be compulsory to consume.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in gut metabolites (from faecal samples) in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
|
Measured by changes in faecal short chain fatty acids concentrations
|
At baseline and end of each arm (study days 1, 15, 29 and 43)
|
|
Change in gut microbiome composition (from faecal samples) in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
|
Measured by changes in bacterial 16S ribosomal ribonucleic acid gene sequencing; 16S rRNA
|
At baseline and end of each arm (study days 1, 15, 29 and 43)
|
|
Change in gut metabolite production (from faecal samples) in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
|
Measured by changes in calprotectin concentrations
|
At baseline and end of each arm (study days 1, 15, 29 and 43)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in free-living glycaemic control in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
|
measured using continuous glucose monitoring (CGM)
|
every day of study diets (42days)
|
|
Change in glycaemic control in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
|
measured by changes in fasted plasma glucose and insulin
|
At baseline and end of each arm (study days 1, 15, 29 and 43)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Height
Time Frame: At screening visit only
|
measured in metres
|
At screening visit only
|
|
Change in concentration of blood metabolites in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
|
measured by changes in fasted plasma short chain fatty acid (SCFA) concentrations
|
At baseline and end of each arm (study days 1, 15, 29 and 43)
|
|
Change in concentration of gut hormones in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
|
measured by changes in fasted plasma ghrelin, GLP-1 and peptide YY (PYY) concentrations
|
At baseline and end of each arm (study days 1, 15, 29 and 43)
|
|
Change in lipid profile in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
|
measured by changes in fasted plasma lipid profile (Total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides and non-esterified fatty acids (NEFA)
|
At baseline and end of each arm (study days 1, 15, 29 and 43)
|
|
Change in lipid ratios in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
|
Total cholesterol, HDL-cholesterol and LDL-cholesterol measures will be combined to report TC to HDL and LDL to HDL ratios.
|
At baseline and end of each arm (study days 1, 15, 29 and 43)
|
|
Change in concentration of urinary metabolites in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
|
changes in urinary metabolite concentrations measured by metabolomics
|
At baseline and end of each arm (study days 1, 15, 29 and 43)
|
|
Change in body weight in response to dietary fibre and non-nutritive sweetener
Time Frame: At screening and 3 times a week on each arm (20 occasions from date of screening up to study day 43)
|
measured as weight in kilograms
|
At screening and 3 times a week on each arm (20 occasions from date of screening up to study day 43)
|
|
Change in Body Mass Index (BMI) in response to dietary fibre and non-nutritive sweetener
Time Frame: At screening and 3 times a week on each arm (20 occasions from date of screening up to study day 43)
|
weight and height measures will be combined to report BMI in kg/m^2
|
At screening and 3 times a week on each arm (20 occasions from date of screening up to study day 43)
|
|
Change in daily nausea symptoms in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
|
measured daily, at end of day, using questionnaires.
Question presented as a Likert scale 'Have you experienced nausea today?', scored as 0 - no more symptoms than usual, 1 - slightly more symptoms than usual, 2 - noticeably more symptoms than usual, 3 - considerably more symptoms than usual.
|
every day of study diets (42days)
|
|
Change in daily bloating symptoms in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
|
measured daily, at end of day, using questionnaires.
Question presented as a Likert scale 'Have you experienced bloating today?', scored as 0 - no more symptoms than usual, 1 - slightly more symptoms than usual, 2 - noticeably more symptoms than usual, 3 - considerably more symptoms than usual.
|
every day of study diets (42days)
|
|
Change in daily flatulence symptoms in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
|
measured daily, at end of day, using questionnaires.
Question presented as a Likert scale 'Have you experienced flatulence today?', scored as 0 - no more symptoms than usual, 1 - slightly more symptoms than usual, 2 - noticeably more symptoms than usual, 3 - considerably more symptoms than usual.
|
every day of study diets (42days)
|
|
Change in daily abdominal cramp symptoms in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
|
measured daily, at end of day, using questionnaires.
Question presented as a Likert scale 'Have you experienced abdominal cramps today?', scored as 0 - no more symptoms than usual, 1 - slightly more symptoms than usual, 2 - noticeably more symptoms than usual, 3 - considerably more symptoms than usual.
|
every day of study diets (42days)
|
|
Change in daily intestinal rumble symptoms in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
|
measured daily, at end of day, using questionnaires.
Question presented as a Likert scale 'Have you experienced rumbles today?
(intestinal sounds)', scored as 0 - no more symptoms than usual, 1 - slightly more symptoms than usual, 2 - noticeably more symptoms than usual, 3 - considerably more symptoms than usual.
|
every day of study diets (42days)
|
|
Change in daily diarrhoea symptoms in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
|
measured daily, at end of day, using questionnaires.
Question presented as a Likert scale 'Have you experienced diarrhoea today?', scored as 0 - no more symptoms than usual, 1 - slightly more symptoms than usual, 2 - noticeably more symptoms than usual, 3 - considerably more symptoms than usual.
|
every day of study diets (42days)
|
|
Change in daily constipation symptoms in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
|
measured daily, at end of day, using questionnaires.
Question presented as a Likert scale 'Have you experienced constipation today?', scored as 0 - no more symptoms than usual, 1 - slightly more symptoms than usual, 2 - noticeably more symptoms than usual, 3 - considerably more symptoms than usual.
|
every day of study diets (42days)
|
|
Change in daily bowel movements in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
|
measured daily, at end of day, using questionnaires.
Question presented as a scale 'How many bowel movements have you had today?',
scored as 0, 1, 2, 3 or >3.
|
every day of study diets (42days)
|
|
Change in daily hunger rating in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
|
measured daily, at end of day, using questionnaires.
Question presented as a visual analogue scale 'How hungry have you felt today?', scored from 0 (Generally not at all hungry) to 100 (Generally as hungry as I've ever felt).
|
every day of study diets (42days)
|
|
Change in daily fullness rating in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
|
measured daily, at end of day, using questionnaires.
Question presented as a visual analogue scale 'How full have you felt today?', scored from 0 (Generally not at all full) to 100 (Generally as full as I've ever felt).
|
every day of study diets (42days)
|
|
Change in daily desire to eat rating in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
|
measured daily, at end of day, using questionnaires.
Question presented as a visual analogue scale 'How strong has your desire to eat been today?',
scored from 0 (Very weak) to 100 (Very strong).
|
every day of study diets (42days)
|
|
Change in retrospective food consumption rating in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
|
measured daily, at end of day, using questionnaires.
Question presented as a visual analogue scale 'How much do you feel you could have eaten today?', scored from 0 (Nothing at all) to 100 (A large amount).
|
every day of study diets (42days)
|
|
Change in appetite in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
|
Mean of hunger, fullness, desire to eat and retrospective consumption ratings will be combined to report an overall appetite score (from 0 to 100)
|
every day of study diets (42days)
|
|
Change in food intake
Time Frame: at screening (7days) and every day of study diets (42days)
|
measured using weighed intake records
|
at screening (7days) and every day of study diets (42days)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alexandra Johnstone, Prof, Rowett Institute, University of Aberdeen
- Principal Investigator: Alexander Ross, Dr, Rowett Institute, University of Aberdeen
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 814
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Appetitive Behavior
-
Iowa State UniversityCompleted
-
University of LeedsCompleted
-
Arne AstrupUniversity of Copenhagen; Arla Foods; Technical University of Denmark; DuPont Nutrition...Withdrawn
-
Purdue UniversityCompletedAppetitive Behavior
-
Wilfrid Laurier UniversityNatural Sciences and Engineering Research Council, CanadaNot yet recruitingAppetitive Behavior
-
University of LeedsCompletedAppetitive BehaviorUnited Kingdom
Clinical Trials on Phase 1 Control
-
Janssen Research & Development, LLCCompletedRelapsed or Refractory Hodgkin LymphomaFrance, Germany
-
Duke UniversityNational Institute of Mental Health (NIMH)Completed
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA)CompletedOpioid Abuse (Disorder)United States
-
Shenzhen Precision Health Food Technology Co. Ltd...CompletedDiabetes | Sugar; Blood, HighChina
-
University of British ColumbiaCompletedDiabetes | Type 2 Diabetes | Orthostatic Hypotension | CardiovascularCanada
-
Brigham and Women's HospitalWithdrawn
-
University of MinnesotaArizona State UniversityCompleted
-
University of Alabama at BirminghamUniversity of Colorado, Denver; National Institute on Aging (NIA); University...RecruitingHIV Infections | Cognitive ImpairmentUnited States
-
Medical University of WarsawNot yet recruitingCoeliac Disease | Celiac Disease in Children